Targeted nanomedicine: Nanotherapeutics to target specific target cells. Engineering and designing of specific advancing nanocarriers. More……
His area of research is advancing ‘nanocarriers’ for combined targeted medicine, in order to enhance efficacy of drug delivery to reach untargetable complex tumor sites. The goal is to hit multiple targets simultaneously at a time to maximize reducing the chances of tumor options. These newer approaches ideally seek to completely immaculate highly complex tumor tissues, that have, thus far, been resistant to available therapies, not only by the elimination of every malignant cell types, but essentially confronting at different molecular levels or pathways.
Dr. Asif Khurshid Qazi, Signal Tranduction
Dr. Asif, Post-graduated in Biochemistry from Kashmir University, Srinagar and Doctorate in Biochemistry from Jamia Hamdard University, New Delhi. He did his Post Doctorate from University of Nebraska Medical Center, USA. He has worked in various capacities at Sheri-I-Kashmir Institute of Medical Sciences (SKIMS), Srinagar and later joined Department of Biochemistry, GMC, Baramulla. Dr. Asif has worked in the field of PI3K signaling and therapeutic strategies by employing novel synthesized molecules and has got high impact publications in peer reviewed international journals like Cancer Letters, Carcinogenesis, Molecular Carcinogenesis, Oncotarget, European Journal of Medicinal Chemistry and many others. Dr. Asif worked in different projects funded by various agencies like CSIR, DBT, DST, ICMR, and NIH. He is a member of many professional societies. He has to his credit many Research publications in International Journals. For his contributions to research he was awarded various fellowships and till date he has guided various Under Graduate and graduate students.